Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04616508 · ClinicalTrials.gov registry record · NA

Online Motor Control in People With Parkinson's Disease

A NA study of Parkinson Disease and Motor Control, sponsored by University of Delaware.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04616508: Recruiting NA study of Parkinson Disease and Motor Control, sponsored by University of Delaware.

NCT04616508 is a NA study of Parkinson Disease and Motor Control that is actively recruiting participants, run by University of Delaware. The registered enrollment target is 100 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04616508, a NA study of Parkinson Disease and Motor Control, is actively recruiting participants, sponsored by University of Delaware.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study aims to better understand how people with Parkinson's control reaching movements. Specifically, we are asking how these individuals respond to different environmental perturbations. Testing includes reaching movements made within a virtual reality set-up.

Primary Outcome

Euclidean distance from target to final hand position (units: cm); measurement derived from position data sampled at 1000 Hz

Interventions

  • BEHAVIORAL motor control assessment

Study Locations (1)

Delaware

  • University of Delaware - Newark

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-12-12
Est. Completion 2026-12-12
Phase NA
University of Delaware

106 total trials

What NCT04616508 shows while recruiting

NCT04616508 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which motor control assessment is the first listed.

NCT04616508 reports a single indexed study location in Delaware.

Frequently Asked Questions

What is clinical trial NCT04616508 about?

NCT04616508 is a clinical study titled "Online Motor Control in People With Parkinson's Disease". This study aims to better understand how people with Parkinson's control reaching movements. Specifically, we are asking how these individuals respond to different environmental perturbations. Testing includes reaching movements made within a virtual reality set-up.

What is the current status of trial NCT04616508?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2018-12-12. Estimated completion is 2026-12-12.

What conditions does trial NCT04616508 study?

This clinical trial studies the following conditions: Parkinson Disease, Motor Control.

What interventions are being tested in trial NCT04616508?

The interventions under investigation include: motor control assessment (BEHAVIORAL).

Who is sponsoring clinical trial NCT04616508?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04616508 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04616508's enrollment target sits among peer trials

100 86th of 297 higher than 207 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04616508, the US trial registry maintained by the National Library of Medicine. NCT04616508 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.